GAMMA Investing’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.6K | Sell |
2,671
-842
| -24% | -$18.2K | ﹤0.01% | 1837 |
|
|
2025
Q1 | $58.4K | Buy |
3,513
+3,030
| +627% | +$50.3K | ﹤0.01% | 1688 |
|
|
2024
Q4 | $8.86K | Buy |
483
+196
| +68% | +$3.6K | ﹤0.01% | 2675 |
|
|
2024
Q3 | $4.41K | Buy |
287
+119
| +71% | +$1.83K | ﹤0.01% | 2794 |
|
|
2024
Q2 | $2.73K | Sell |
168
-195
| -54% | -$3.17K | ﹤0.01% | 2791 |
|
|
2024
Q1 | $6.71K | Sell |
363
-21
| -5% | -$388 | ﹤0.01% | 2265 |
|
|
2023
Q4 | $9.95K | Buy |
+384
| New | +$9.95K | ﹤0.01% | 1906 |
|